Abstract
Three cases of ocular damage which occurred during or shortly after the use of oral contraceptive compounds are reported. Although ocular complications are rare, they should be kept in mind since immediate treatment may prove sight-saving, as demonstrated by these cases. While no direct relationship between estrogen dosage and incidence of thromboembolic diseases has been definitely established, it is recommended that contraceptive pills containing lower dosages of estrogen be used.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
